Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose vs Low-Dose Simvastatin in Acute Ischemic Stroke
NCT03402204Phase 3Completed
- Sponsor
- Thammasat University
- Start
- Apr 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of simvastatin in ischemic stroke (2 arms), sponsored by Thammasat University. Primary endpoint: Vascular Oxidative Stress (sLOX-1 and NO levels) at 180 days. Started Apr 2014; status: completed.
02
Drugs
simvastatin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03402204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03402204.